|
duckduckgo
|
UCB Completes Acquisition of Zogenix, Inc.
|
|
fool
|
Why Zogenix Stock Is on Fire Today
|
|
investors
|
Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest
|
|
barrons
|
Zogenix Stock Rockets on News of Acquisition by UCB
|
|
duckduckgo
|
Should I Avoid Zogenix, Inc. ?
|
|
yahoo
|
Zogenix, Inc. : Hedge Funds Are Snapping Up - Yahoo Finance
|
|
fool
|
3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023
|
|
nasdaq
|
3 “Strong Buy” Stocks That Just Bottomed
|
|
yahoo
|
Do Hedge Funds Love Zogenix, Inc. ?
|
|
yahoo
|
Is ZGNX Stock A Buy or Sell?
|
|
yahoo
|
Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies for Dravet Syndrome and Other Genetic Epilepsies
|
|
simplywall.st
|
Read This Before Selling Zogenix, Inc. Shares
|
|
yahoo
|
Analysts Have Just Cut Their Zogenix, Inc. Revenue Estimates By 0.7%
|
|
yahoo
|
Does Zogenix's CEO Salary Compare Well With The Performance Of The Company?
|
|
yahoo
|
These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
|
|
zacks
|
Zogenix Reports Q2 Loss, Misses Revenue Estimates
|
|
yahoo
|
Did Hedge Funds Make The Right Call On Zogenix, Inc. ?
|
|
gurufocus
|
Zogenix's Long-Awaited Drug Approved With a Warning
|
|
zacks
|
Zogenix in Focus: Stock Moves 7.6% Higher
|
|
zacks
|
Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More
|
|
yahoo
|
FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
|
|
smarteranalyst
|
Zogenix’s Fintepla Gains FDA Approval, but Analyst Sees Challenging Launch Ahead
|
|
marketwatch
|
Zogenix's shares rise on FDA approval of seizure drug
|
|
zacks
|
Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment
|
|
yahoo
|
Zogenix Finally Receives FDA Nod For Fintepla, Analysts Bullish On Outlook
|
|
prnewswire
|
FDA Approves FINTEPLA® for the Treatment of Seizures Associated with Dravet Syndrome
|
|
in.reuters
|
FDA approves Zogenix's drug for rare childhood epilepsy
|
